Related Experiment Video
Updated: May 15, 2025
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Saudi clinical practice guidelines for the treatment and prevention of migraine headache
Faisal A Al-Suwaidan1, Hajer Y Almudaiheem1, Haifa F Alotaibi1
1from the Division of Neurology (Al-Suwaidan), Department of Medicine, Security Forces Hospital, Neurology Clinical Lead (Al-Suwaidan), Ministry of Health, from the College of Medicine (Al-Suwaidan), Princess Nourah Bint Abdulrahman University, from the College of Medicine (Al-Suwaidan), Dar Al-Uloom University, from Scientific Research Centre (Alotaibi, Alhazzani), Ministry of Defence Health Services, from the Department of Pharmaceutical Care Services (Al-Omari), Prince Sultan Military Medical City, from King Saud Medical City (Omaer), from Department of Family Medicine (Alrajhi), Administration of Anesthesiology & Perioperative Medicine (Alshoaiby), King Fahad Medical City, from the Colleges of Medicine and Pharmacy (Al-Jedai), Alfaisal University, from the Solid Organ Transplant (Al-Jedai), King Faisal Specialist Hospital & Research Centre, from The Saudi Society of Clinical Pharmacy (Al-Jedai, Almudaiheem), Riyadh, Saudi Arabia, and from the Department of Medicine (Al-Quliti), College of Medicine, Taibah University, National Guard Hospital, Madinah, and from Executive Management of Transformation, Planning, and Business Development (Alenzi), Tabuk Health Cluster, Tabuk, and from the Department of Neurology (Alabdali), College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Kingdom of Saudi Arabia.
Objective:
To develop clinical practice guidelines based on evidence based medicine on the use of abortive and preventive therapies for managing migraine headaches. We formulated these guidelines to offer evidence-based recommendations to improve the knowledge of physicians, healthcare professionals, and policymakers in migraine headache management.
Method:
A panel of 11 experts from different sectors in Saudi Arabia approved 26 questions on abortive and preventive therapies for migraines. To develop each question, we searched "PubMed" and "Cochrane Library" databases for recent relevant systematic reviews published between 2013 and 2024. We employed the Grading Recommendations, Assessment, Development, and Evaluation methodological approach to ensure the certainty of the collated evidence and to formulate the recommendations. The expert panel voted electronically on each recommendation, and a consensus was defined as >70% agreement.
Results:
We formulated a total of 26 recommendations. Of these, 14 are focused on abortive therapy for acute migraine attacks, whereas 12 are focused on the prevention of episodic or chronic migraines. These guidelines strongly recommend the use of paracetamol and ibuprofen as the first-line treatment for mild to moderate migraine. Furthermore, we concluded that propranolol should be considered as the first-line preventive intervention for migraine.
Conclusion:
The Saudi clinical practice guidelines offer systematically validated recommendations of migraine headaches in adults. The recommendations are potentially beneficial for all healthcare professionals managing patients with migraine headaches.
Related Concept Videos
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
01:30Preventive Healthcare Services